Seattle-based Stratos Genomics, developer of low-cost gene sequencing technology, says it has added $2.1 million in financing from existing investors, tied to last year’s $4 million Series A round. In a press release, CEO Allan Stephan said shareholders “don’t want our validation pace interrupted by external fundraising activities.” Stratos Genomics was founded in 2007 as a spinoff from Stratos Group, the parent company of Seattle’s Stratos Product Development.
Author: Curt Woodward
Curt covered technology and innovation in the Boston area for Xconomy. He previously worked in Xconomy’s Seattle bureau and continued some coverage of Seattle-area tech companies, including Amazon and Microsoft.
Curt joined Xconomy in February 2011 after nearly nine years with The Associated Press, the world's largest news organization. He worked in three states and covered a wide variety of beats for the AP, including business, law, politics, government, and general mayhem.
A native Washingtonian, Curt earned a bachelor's degree in journalism from Western Washington University in Bellingham, WA. As a past president of the state's Capitol Correspondents Association, he led efforts to expand statehouse press credentialing to online news outlets for the first time.
View all posts by Curt Woodward
